Abstract
A 17-year-old boy with an eight-month history of cutaneous leishmaniasis on the left earlobe was treated with ketoconazole for a period of four weeks. The patient showed excellent improvement both clinically and protozoologically. Ketoconazole, a new imidazole bound covalently to piperazine, has been developed as a broad spectrum antimycotic agent and appears to be a good antileishmanial drug.
| Original language | English |
|---|---|
| Pages (from-to) | 288-289+294 |
| Journal | Cutis |
| Volume | 32 |
| Issue number | 3 |
| State | Published - 1 Jan 1983 |
| Externally published | Yes |
ASJC Scopus subject areas
- Dermatology